Human medicines European public assessment report (EPAR): Laventair Ellipta (previously Laventair), umeclidinium bromide,...
Laventair Ellipta and a higher-dose combination of umeclidinium bromide and vilanterol were compared with placebo (a dummy treatment), vilanterol alone, umeclidinium bromide alone and another COPD medicine called tiotropium in 4 main studies. In all 4 …